# Thermo Fisher Scientific (TMO) free cash flow history

URL: https://funkfolio.com/stock/TMO/free-cash-flow

> Thermo Fisher Scientific (TMO) free cash flow was $6.29B in fiscal 2025, down 13.4% from fiscal 2024. Over five fiscal years it shrank 1.6% a year.

---

## Thermo Fisher Scientific (TMO) free cash flow

**Free cash flow · fiscal 2025:** $6.29B year ended Dec 31, 2025

Thermo Fisher Scientific (TMO) generated free cash flow of $6.29B in fiscal 2025 (the year ended December 31, 2025). That is 13.4% lower than the $7.27B of fiscal 2024. Figures as of 18 Nov 2026, 12:35 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Free cash flow, fiscal 2025:** $6.29B
- **Change on fiscal 2024:** −13.4%
- **Growth, 5 years:** −1.6% a year
- **Growth, 10 years:** +9.6% a year
- **Highest on record:** $7.27B fiscal 2024
- **Lowest on record:** $1.16B fiscal 2008
- **Fiscal years on record:** 19 2007–2025

Figures as of 18 Nov 2026, 12:35 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Thermo Fisher Scientific free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 1.6% a year; over ten years the rate was 9.6% a year. Across the 19 fiscal years on record (2007–2025), the highest was $7.27B in fiscal 2024 and the lowest $1.16B in fiscal 2008.

### Free cash flow by fiscal year

### Thermo Fisher Scientific free cash flow, year by year

Thermo Fisher Scientific (TMO) free cash flow by fiscal year

| Fiscal year | Free cash flow | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | $6.29B | 13.4% down | Dec 31, 2025 |
| 2024 | $7.27B | 4.9% up | Dec 31, 2024 |
| 2023 | $6.93B | 0.2% up | Dec 31, 2023 |
| 2022 | $6.91B | 1.8% up | Dec 31, 2022 |
| 2021 | $6.79B | 0.4% down | Dec 31, 2021 |
| 2020 | $6.82B | 68.4% up | Dec 31, 2020 |
| 2019 | $4.05B | 6.9% up | Dec 31, 2019 |
| 2018 | $3.79B | 8.2% up | Dec 31, 2018 |
| 2017 | $3.50B | 24.3% up | Dec 31, 2017 |
| 2016 | $2.81B | 11.7% up | Dec 31, 2016 |
| 2015 | $2.52B | 14.9% up | Dec 31, 2015 |
| 2014 | $2.19B | 26.8% up | Dec 31, 2014 |
| 2013 | $1.73B | 0.2% up | Dec 31, 2013 |
| 2012 | $1.72B | 20.6% up | Dec 31, 2012 |
| 2011 | $1.43B | 14.2% up | Dec 31, 2011 |
| 2010 | $1.25B | 14.2% down | Dec 31, 2010 |
| 2009 | $1.46B | 26.3% up | Dec 31, 2009 |
| 2008 | $1.16B | 11.6% down | Dec 31, 2008 |
| 2007 | $1.31B | — | Dec 31, 2007 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

### How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

### Free cash flow at health care companies of similar size

Free cash flow of Thermo Fisher Scientific and comparable companies

| Company | Free cash flow | Fiscal year |
| --- | --- | --- |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/free-cash-flow) | $16.08B | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/free-cash-flow) | $15.24B | 2025 |
| [AstraZeneca AZN](https://funkfolio.com/stock/AZN/free-cash-flow) | $8.67B | 2025 |
| Thermo Fisher Scientific TMO | $6.29B | 2025 |
| [Amgen AMGN](https://funkfolio.com/stock/AMGN/free-cash-flow) | $8.10B | 2025 |
| [Gilead Sciences GILD](https://funkfolio.com/stock/GILD/free-cash-flow) | $9.46B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Thermo Fisher Scientific, figure by figure

- [Thermo Fisher Scientific market cap](https://funkfolio.com/stock/TMO/market-cap)
- [Thermo Fisher Scientific revenue](https://funkfolio.com/stock/TMO/revenue)
- [Thermo Fisher Scientific earnings](https://funkfolio.com/stock/TMO/earnings)
- [Thermo Fisher Scientific earnings per share (EPS)](https://funkfolio.com/stock/TMO/eps)
- [Thermo Fisher Scientific P/E ratio](https://funkfolio.com/stock/TMO/pe-ratio)
- [Thermo Fisher Scientific P/S ratio](https://funkfolio.com/stock/TMO/ps-ratio)
- [Thermo Fisher Scientific P/B ratio](https://funkfolio.com/stock/TMO/pb-ratio)
- [Thermo Fisher Scientific operating margin](https://funkfolio.com/stock/TMO/operating-margin)
- [Thermo Fisher Scientific dividend](https://funkfolio.com/stock/TMO/dividend)
- [Thermo Fisher Scientific shares outstanding](https://funkfolio.com/stock/TMO/shares-outstanding)
- [Thermo Fisher Scientific total debt](https://funkfolio.com/stock/TMO/total-debt)
- [Thermo Fisher Scientific cash on hand](https://funkfolio.com/stock/TMO/cash)
- [Thermo Fisher Scientific total assets](https://funkfolio.com/stock/TMO/total-assets)
- [Thermo Fisher Scientific return on equity (ROE)](https://funkfolio.com/stock/TMO/roe)
- [Thermo Fisher Scientific return on invested capital (ROIC)](https://funkfolio.com/stock/TMO/roic)

[Thermo Fisher Scientific (TMO) overview: price, valuation and scorecard](https://funkfolio.com/stock/TMO) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Thermo Fisher Scientific free cash flow: questions and answers

**What is Thermo Fisher Scientific's free cash flow?**

Thermo Fisher Scientific (TMO) generated free cash flow of $6.29B in fiscal 2025 (the year ended December 31, 2025). That is 13.4% lower than the $7.27B of fiscal 2024.

**What is the growth rate of Thermo Fisher Scientific's free cash flow?**

Over the five fiscal years to 2025 free cash flow shrank at a compound 1.6% a year; over ten years the rate was 9.6% a year.

**What are the highest and lowest free cash flow figures on record for Thermo Fisher Scientific?**

Across the 19 fiscal years on record (2007–2025), the highest was $7.27B in fiscal 2024 and the lowest $1.16B in fiscal 2008.

**How is Thermo Fisher Scientific's free cash flow calculated?**

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Thermo Fisher Scientific it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: free cash flow

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
- [How a DCF valuation works, and why inputs swing it](https://funkfolio.com/learn/stocks/dcf-valuation)

  A discounted cash flow (DCF) valuation estimates what a business is worth today by forecasting the cash it will produce and discounting each year's cash back at a required rate of return. Because most of the value lies far in the future, a one-point change in growth or discount rate can move the answer by a quarter.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Thermo Fisher Scientific (TMO) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/TMO/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.
